Today's guest John Hall, Ph.D. discusses the Beljanski Foundation and its natural approach to cancer. John has served as an Executive in the Biotechnology Industry and is currently Vice President for Research and Development at Molecular International Research and Director of Research at The Beljanski Foundation. Dr. Hall was a Graduate Fellow at Princeton University, in the Department of Biochemical Sciences, and he completed his Ph.D. at New York University, in the Department of Biochemistry. In this episode, John Hall explains the nutraceuticals behind the amazing Beljanski product Onkobel-Pro as well as the purified RNA extract, Immunobel-Pro. The two anti-cancer plant extracts in Onkobel pro were originally developed by Mirko Beljanski as a natural approach to cancer. They have been shown to help those diagnosed with as well as those who want to prevent cancer. In addition, listen in to learn about some new and exciting research that the foundation is funding, beneficial to late-stage cancers.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related